Skip to main content
OpenTrials
Completed

NCT Number: NCT03904810

Low-frequency High-Intensity Interval Training in Overweight or Obese Young Adults

Background: The relationship between the frequency of high-intensity interval training (HIIT) and the resultant adaptations is largely unclear. Purpose: This study examined the effects of different frequencies of HIIT compared to moderate-intensity continuous training (MICT) on body composition and cardiovascular biomarkers in overweight or obese adults. Methods: This study was a randomized, controlled, single-blinded trial. Fifty-six overweight or obese men aged between 18 and 30 years were randomly assigned to no-intervention control (CON; n=14), MICT performed thrice weekly (MICT×3/wk; n=9), HIIT performed thrice weekly (HIIT×3/wk; n=14), HIIT performed twice weekly (HIIT×2/wk; n=10), and HIIT performed once weekly (HIIT×1/wk; n=9). Each HIIT session consisted of 12 × 1-min bouts at 90% heart rate reserve (HRR), interspersed with 11 × 1-min bouts at 70% HRR (HIIT×3/wk: 69 min/wk; HIIT×2/wk: 46 min/wk; HIIT×1/wk: 23 min/wk). Aerobic capacity, resting heart rate, body composition, waist circumference, blood pressure, endothelial function, fasting blood glucose and lipids, circulatory adipokines and inflammatory biomarkers were examined at baseline, after 4 weeks and 8 weeks of intervention.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Overweight and Obesity Body Weight Nutrition Disorders Nutritional and Metabolic Diseases Obesity Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–30 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

LKS Faculty of Medicine

Hong Kong

About this study

Individuals who fulfilled the following inclusion criteria were invited to participate in the present study: 1) Chinese male; 2) aged 18-30 years; and 3) overweight or obesity, defined as BMI ≥23 kg/m2 (classification of overweight for Hong Kong adults according to Department of Health, Hong Kong SAR Government) (13). Subjects were excluded if they had: 1) chronic medical and health condition such as cardiovascular diseases, diabetes, neurological disease, musculoskeletal disorder, cancers, and autoimmune diseases; 2) hypertension (blood pressure >140/90 mmHg); 3) contraindications to participating in physical exercise; 4) any pre-existing medical or physical issues that affected the experimental test; 5) physically active (i.e., >3 hours of moderate-intensity exercise weekly) or 6) lean overweight population (BMI ≥23 kg/m2, but percent body fat ≤20%) according to the BMI data corresponding to bioelectrical impedance estimated percent body fat cut-off value among Hong Kong Chinese adults.

Of those who were screened, 103 Chinese young adults were eligible to participate in this study. They were provided with written and verbal information on the study protocol and the possible associated discomforts and risks followed by obtaining their written informed consent to participate in this study. The study protocol and consent form were approved by the Human Subjects Ethics Sub-Committee of The Hong Kong Polytechnic University (ethics approval reference number: HSEARS20160927005-01).

This study was a single-blind, randomized, controlled trial. Subjects were randomly assigned to 1) no-intervention control (CON), 2) MICT performed thrice weekly (MICTx3/wk), 3) HIIT performed thrice weekly (HIITx3/wk), 4) twice weekly (HIITx2/wk), and 5) once weekly (HIITx1/wk). All subjects were instructed to maintain their usual daily activities. Outcome measures including aerobic capacity, body composition, blood pressure, resting heart rate, endothelial function, arterial stiffness, fasting glucose, lipids markers, adipokine marker, and inflammatory marker were assessed at baseline, 4 weeks and 8 weeks after the intervention.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Chinese male
  • Aged 18-30 years
  • Overweight or obesity, defined as BMI ≥23 kg/m2 (classification of overweight for Hong Kong adults according to Department of Health, Hong Kong SAR Government)

Exclusion criteria

  • Chronic medical and health condition such as cardiovascular diseases, diabetes, neurological disease, musculoskeletal disorder, cancers, and autoimmune diseases
  • Hypertension (blood pressure >140/90 mmHg)
  • Contraindications to participating in physical exercise
  • Any pre-existing medical or physical issues that affected the experimental test
  • Physically active (i.e., >3 hours of moderate-intensity exercise weekly)
  • Lean overweight population (BMI ≥23 kg/m2, but percent body fat ≤20%) according to the BMI data corresponding to bioelectrical impedance estimated percent body fat cut-off value among Hong Kong Chinese adults.

Treatment and study plan

Exercise Intervention

Behavioral

HIIT groups performed 30-meter shuttle runs on a rooftop covered field whereas MICT group ran on a footpath with an overall flat and non-slippery road surface. All training sessions were preceded by a 5-minute self-pace warm-up jogging and ended with a 5-minute self-pace jogging or walking cool-down. Each session of MICT consisted of 30 minutes of continuous exercise at an intensity of 60% of heart rate reserve (HRR); [i.e., (maximal HR - resting HR) × intensity + resting HR]. For each HIIT session, the intensity was set at 90% HRR for high-intensity bouts, interspersed with active recovery at 70% HRR. All exercise sessions were supervised by qualified athletic coach or strength and conditioning coach.

Primary outcomes

  1. Estimated maximal oxygen consumption

    Time frame: 8 weeks

    Estimated maximal oxygen consumption achieved during the 20-meter shuttle multistage run test were used for the assessment of aerobic fitness Unit: body weight, estimated oxygen consumption and minute will be combined to report the estimated VO2max in ml/kg/min.

  2. Total running distance

    Time frame: 8 weeks

    Total running distance in meters achieved during the 20-meter shuttle multistage run test were used for the assessment of aerobic fitness

  3. Total body fat percentage

    Time frame: 8 weeks

    Total body fat percentage were assessed by a bioelectrical impedance analyzer (BC-418, Tanita, Japan).

  4. Total body fat mass

    Time frame: 8 weeks

    Total body fat mass in kg were assessed by a bioelectrical impedance analyzer (BC-418, Tanita, Japan).

  5. Total body fat-free mass percentage

    Time frame: 8 weeks

    Total body fat-free mass percentage were assessed by a bioelectrical impedance analyzer (BC-418, Tanita, Japan).

  6. Total fat-free mass

    Time frame: 8 weeks

    Total body fat-free mass were assessed by a bioelectrical impedance analyzer (BC-418, Tanita, Japan).

  7. Trunk fat mass

    Time frame: 8 weeks

    Trunk fat mass in kg were assessed by a bioelectrical impedance analyzer (BC-418, Tanita, Japan).

  8. Body weight

    Time frame: 8 weeks

    Body weight in kg were assessed by a bioelectrical impedance analyzer (BC-418, Tanita, Japan).

  9. Body height

    Time frame: 8 weeks

    Body height in meter were assessed.

  10. Body mass index (BMI)

    Time frame: 8 weeks

    Weight and height will be combined to report BMI in kg/m^2

  11. Waist circumference

    Time frame: 8 weeks

    Waist circumference was determined to the nearest 0.1 cm of a contact tension tape. The tape was applied directly to the skin at the mid-point between the lower margin of the last palpable rib and the top of the iliac crest.

Secondary outcomes

  1. Systolic blood pressure

    Time frame: 8 weeks

    Systolic blood pressure was determined by an electronic sphygmomanometer (Accutorr Plus, Datascope, USA)

  2. Diastolic blood pressure

    Time frame: 8 weeks

    Diastolic blood pressure was determined by an electronic sphygmomanometer (Accutorr Plus, Datascope, USA)

  3. Mean arterial pressure

    Time frame: 8 weeks

    Mean arterial pressure was determined by an electronic sphygmomanometer (Accutorr Plus, Datascope, USA)

  4. Resting heart rate

    Time frame: 8 weeks

    Resting heart rate was determined by an electronic sphygmomanometer (Accutorr Plus, Datascope, USA)

  5. Endothelial function

    Time frame: 8 weeks

    Endothelial function were measured by digital plethysmography using EndoPAT 2000 device (ITAMAR Medical, Caesarea, Israel) and expressed as natural log reactive hyperemia index (LnRHI)

  6. Arterial stiffness

    Time frame: 8 weeks

    Arterial stiffness were measured by digital plethysmography using EndoPAT 2000 device (ITAMAR Medical, Caesarea, Israel) and expressed as augmentation index normalized to heart rate of 75 bpm (AI@75)

  7. Serum fasting glucose

    Time frame: 8 weeks

    Fresh blood samples were sent to an accredited medical laboratory to measure the serum fasting glucose concentrations by commercial test kit methods with an automatic clinical chemistry analyzer (Architect CI8200, Abbott Diagnostics, USA)

  8. Triglycerides

    Time frame: 8 weeks

    Fresh blood samples were sent to an accredited medical laboratory to measure the serum triglycerides concentrations by commercial test kit methods with an automatic clinical chemistry analyzer (Architect CI8200, Abbott Diagnostics, USA)

  9. High-density lipoproteins (HDL) cholesterol

    Time frame: 8 weeks

    Fresh blood samples were sent to an accredited medical laboratory to measure the serum high-density lipoproteins-cholesterol (HDL-C) concentrations by commercial test kit methods with an automatic clinical chemistry analyzer (Architect CI8200, Abbott Diagnostics, USA)

  10. Low-density lipoprotein (LDL) cholesterol

    Time frame: 8 weeks

    Low-density lipoprotein (LDL) cholesterol in serum was measured by an automatic chemistry analyzer (AU-480, Beckman Coulter, USA)

  11. Interleukin 6

    Time frame: 8 weeks

    Commercially available enzyme-linked immunosorbent assay kits (R&D systems, Minneapolis, MN) were used to determine interleukin 6

  12. Tumor necrosis factor alpha

    Time frame: 8 weeks

    Commercially available enzyme-linked immunosorbent assay kits (R&D systems, Minneapolis, MN) were used to determine tumor necrosis factor alpha

  13. C-reactive protein

    Time frame: 8 weeks

    Commercially available enzyme-linked immunosorbent assay kits (R&D systems, Minneapolis, MN) were used to determine c-reactive protein

  14. Adiponectin

    Time frame: 8 weeks

    Commercially available enzyme-linked immunosorbent assay kits (R&D systems, Minneapolis, MN) were used to determine adiponectin

  15. Intercellular adhesion molecule-1

    Time frame: 8 weeks

    Commercially available enzyme-linked immunosorbent assay kits (R&D systems, Minneapolis, MN) were used to determine intercellular adhesion molecule-1

  16. Vascular cell adhesion molecule-1

    Time frame: 8 weeks

    Commercially available enzyme-linked immunosorbent assay kits (R&D systems, Minneapolis, MN) were used to determine vascular cell adhesion molecule-1

Sponsors and collaborators

Lead sponsor

The University of Hong Kong

Other

Registry information

Official study title

The Effectiveness of Low-frequency High-Intensity Interval Training (HIIT) in Overweight or Obese Young Adults

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Apr 5, 2019
Registry last updated
Apr 5, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.